Literature DB >> 33628188

DNA Repair Pathways in Cancer Therapy and Resistance.

Lan-Ya Li1,2, Yi-di Guan1, Xi-Sha Chen1, Jin-Ming Yang3, Yan Cheng1.   

Abstract

DNA repair pathways are triggered to maintain genetic stability and integrity when mammalian cells are exposed to endogenous or exogenous DNA-damaging agents. The deregulation of DNA repair pathways is associated with the initiation and progression of cancer. As the primary anti-cancer therapies, ionizing radiation and chemotherapeutic agents induce cell death by directly or indirectly causing DNA damage, dysregulation of the DNA damage response may contribute to hypersensitivity or resistance of cancer cells to genotoxic agents and targeting DNA repair pathway can increase the tumor sensitivity to cancer therapies. Therefore, targeting DNA repair pathways may be a potential therapeutic approach for cancer treatment. A better understanding of the biology and the regulatory mechanisms of DNA repair pathways has the potential to facilitate the development of inhibitors of nuclear and mitochondria DNA repair pathways for enhancing anticancer effect of DNA damage-based therapy.
Copyright © 2021 Li, Guan, Chen, Yang and Cheng.

Entities:  

Keywords:  DNA damage; DNA repair pathways; cancer therapy; drug resistance; mitochondrial DNA

Year:  2021        PMID: 33628188      PMCID: PMC7898236          DOI: 10.3389/fphar.2020.629266

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  36 in total

Review 1.  Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.

Authors:  Muhammad Tufail; Jia Cui; Changxin Wu
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

Review 2.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

3.  Decoding mechanism of action and sensitivity to drug candidates from integrated transcriptome and chromatin state.

Authors:  Caterina Carraro; Lorenzo Bonaguro; Jonas Schulte-Schrepping; Arik Horne; Marie Oestreich; Stefanie Warnat-Herresthal; Tim Helbing; Michele De Franco; Kristian Haendler; Sach Mukherjee; Thomas Ulas; Valentina Gandin; Richard Goettlich; Anna C Aschenbrenner; Joachim L Schultze; Barbara Gatto
Journal:  Elife       Date:  2022-08-31       Impact factor: 8.713

Review 4.  Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer.

Authors:  Sze Wan Hung; Yiran Li; Xiaoyan Chen; Kai On Chu; Yiwei Zhao; Yingyu Liu; Xi Guo; Gene Chi-Wai Man; Chi Chiu Wang
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

Review 5.  Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2.

Authors:  Gareth Chin Khye Ang; Amogh Gupta; Uttam Surana; Shirlyn Xue Ling Yap; Reshma Taneja
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

6.  Editorial: Chemo-Radiation-Resistance in Cancer Therapy.

Authors:  Xiaoping Lin; Dexin Kong; Zhe-Sheng Chen
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

Review 7.  Chemotherapy and Physical Therapeutics Modulate Antigens on Cancer Cells.

Authors:  Wojciech Szlasa; Natalia Janicka; Natalia Sauer; Olga Michel; Bernadetta Nowak; Jolanta Saczko; Julita Kulbacka
Journal:  Front Immunol       Date:  2022-07-06       Impact factor: 8.786

Review 8.  Research Progress on the Anticancer Activities and Mechanisms of Polysaccharides From Ganoderma.

Authors:  Man Wang; Fei Yu
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

Review 9.  The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.

Authors:  Pui-Wah Choi; Tin Lun Liu; Chun Wai Wong; Sze Kei Liu; Yick-Liang Lum; Wai-Kit Ming
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

Review 10.  Trends in kinase drug discovery: targets, indications and inhibitor design.

Authors:  Misty M Attwood; Doriano Fabbro; Aleksandr V Sokolov; Stefan Knapp; Helgi B Schiöth
Journal:  Nat Rev Drug Discov       Date:  2021-08-05       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.